Insider Transactions
Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Jan 02, 2024 | Director, President and CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 7,500 | $8.61 | 955,305 | |
Jan 02, 2024 | Director, President and CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 7,500 | $14.24 | 947,805 | |
Jan 02, 2024 | Director, President and CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 8,333 | $12.28 | 956,138 | |
Jan 02, 2024 | Director, President and CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 8,333 | $14.23 | 947,805 | |
Jan 02, 2024 | Director, President and CEO | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 265,517 | -- | 265,517 | |
Jan 02, 2024 | Director, President and CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 7,500 | -- | 82,500 | |
Jan 02, 2024 | Director, President and CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 8,333 | -- | 91,667 | |
Jan 02, 2024 | Chief Development Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 57,392 | -- | 398,053 | |
Jan 02, 2024 | Chief Development Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 8,038 | $14.24 | 390,015 | |
Jan 02, 2024 | Chief Development Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 99,073 | -- | 99,073 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.